Wave Life Sciences Ltd. SEC Filing (Aug 12, 2026)

This article reports on an SEC Form 144 filing by Wave Life Sciences Ltd. (WVE) on August 12, 2026. The filing indicates a proposed sale of 12,700 shares of common stock by an individual, acquired through Restricted Stock Units, with an aggregate market value of $64,071.50. The transaction involves Morgan Stanley Smith Barney LLC as the broker and is scheduled for August 12, 2026.